Agents that modulate DNA-PK activity and methods of use thereof
View Patent ↗The present invention provides methods for modulating cell death in a eukaryotic cell, and methods for reducing DNA damage in a eukaryotic cell. The methods generally comprise modulating a biological activity of DNA-PK in a cell. The invention further provides methods of treating a condition related to cell death in an individual. The invention further provides methods of identifying agents which modulate a biological activity of DNA-PK, as well as agents identified by the methods. Methods of modulating an immune response using an identified agent are also provided.
1. A method for identifying an agent that modulates a biological activity of DNA-PK, comprising:
a) adding an agent to be tested to a sample, the sample comprising DNA-PK and an immunomodulatory nucleic acid molecule, under conditions which favor binding of the immunomodulatory nucleic acid molecule to DNA-PK, thereby forming a test sample, wherein the immunomodulatory nucleic acid molecule is a DNA molecule that, when bound to Ku antigen, activates DNA-PKcs, wherein the immunomodulatory nucleic acid molecule comprises a nucleotide sequence selected from 5′-Purine-Purine-C-G-Pyrimidine-Pyrimidine-3′,5′-Purine-TCG-Pyrimidine-Pyrimidine-3′,5′-(TCG) n -3′, where n is an integer that is 1 or greater, 5′-Purine-TCG-Pyrimidine-Pyrimidine-CG-3′, and 5′-Purine-Purine-CG-Pyrimidine-Pyrimidine-CG-3′; and
b) detecting a biological activity of DNA-PK protein in the test sample, as compared to a control sample lacking the agent, wherein an increase or a decrease in the biological activity of DNA-PK indicates that the agent modulates a biological activity of DNA-PK.
2. The method of claim 1 , wherein the biological activity of DNA-PK is binding to an immunomodulatory nucleic acid molecule.
3. The method according to claim 2 , wherein the method is a cell-free method, and the immunomodulatory nucleic acid molecule is detectably labeled.
4. The method of claim 1 , wherein the biological activity of DNA-PK is activation of DNA-PKcs kinase activity.
5. The method of claim 1 , wherein the method is a cell-based method and modulation of DNA-PK activity is detected by measuring an amount of IL-6 or IL-12 produced by the cell.
6. A method for identifying an agent that modulates a biological activity of DNA-PK, comprising:
a) adding an agent to be tested to a sample, the sample comprising DNA-PK and an immunomodulatory nucleic acid molecule, under conditions which favor binding of the immunomodulatory nucleic acid molecule to DNA-PK, thereby forming a test sample, wherein the immunomodulatory nucleic acid molecule is a DNA molecule that, when bound to Ku antigen, activates DNA-PKcs, wherein the immunomodulatory nucleic acid molecule comprises a nucleotide sequence selected from 5′-Purine-Purine-C-G-Pyrimidine-Pyrimidine-3′,5′-Purine-TCG-Pyrimidine-Pyrimidine-3′;5′-(TCG) n -3′, where n is an integer that is 1 or greater, 5′-Purine-TCG-Pyrimidine-Pyrimidine-CG-3′, and 5′-Purine-Purine-CG-Pyrimidine-Pyrimidine-CG-3′; and
b) detecting a biological activity of DNA-PK protein in the test sample, as compared to a control sample lacking the agent, wherein an increase or a decrease in the biological activity of DNA-PK indicates that the agent modulates a biological activity of DNA-PK, wherein the biological activity of DNA-PK is selected from activation of DNA-PKcs kinase activity and binding to Ku antigen.